First Time Loading...

Bio Rad Laboratories Inc
NYSE:BIO

Watchlist Manager
Bio Rad Laboratories Inc Logo
Bio Rad Laboratories Inc
NYSE:BIO
Watchlist
Price: 300.34 USD 2.15% Market Closed
Updated: May 15, 2024

Bio Rad Laboratories Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bio Rad Laboratories Inc
Cost of Revenue Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Bio Rad Laboratories Inc
NYSE:BIO
Cost of Revenue
-$1.2B
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
-2%
Thermo Fisher Scientific Inc
NYSE:TMO
Cost of Revenue
-$25.8B
CAGR 3-Years
-17%
CAGR 5-Years
-14%
CAGR 10-Years
-13%
Danaher Corp
NYSE:DHR
Cost of Revenue
-$18.2B
CAGR 3-Years
-20%
CAGR 5-Years
-20%
CAGR 10-Years
-7%
Mettler-Toledo International Inc
NYSE:MTD
Cost of Revenue
-$1.5B
CAGR 3-Years
-5%
CAGR 5-Years
-4%
CAGR 10-Years
-3%
Agilent Technologies Inc
NYSE:A
Cost of Revenue
-$3.3B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-7%
IQVIA Holdings Inc
NYSE:IQV
Cost of Revenue
-$9.7B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-10%

See Also

What is Bio Rad Laboratories Inc's Cost of Revenue?
Cost of Revenue
-1.2B USD

Based on the financial report for Mar 31, 2024, Bio Rad Laboratories Inc's Cost of Revenue amounts to -1.2B USD.

What is Bio Rad Laboratories Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-2%

Over the last year, the Cost of Revenue growth was 4%. The average annual Cost of Revenue growth rates for Bio Rad Laboratories Inc have been -2% over the past three years , -3% over the past five years , and -2% over the past ten years .